| Original language | English |
|---|---|
| Pages (from-to) | 784-785 |
| Number of pages | 2 |
| Journal | PharmacoEconomics |
| Volume | 28 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anticoagulants, therapeutic use
- Antithrombotics, therapeutic use
- Ardeparin-sodium, therapeutic use
- Cost-effectiveness
- Dabigatran-etexilate, therapeutic use
- Dalteparin-sodium, therapeutic use
- Deep-vein-thrombosis, prevention
- Enoxaparin-sodium, therapeutic use
- Factor-Xa-inhibitors, therapeutic use
- Fondaparinux-sodium, therapeutic use
- Low-molecular-weight-heparins, therapeutic use
- Pulmonary-embolism, prevention
- Research-and-development
- Rivaroxaban, therapeutic use
- Tinzaparin-sodium, therapeutic use
- Warfarin, therapeutic use
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver